Safety, strength and simplicity of efavirenz in pregnancy
The WHO recommends starting lifelong ART for all pregnant women with a CD4 count at or below 350 cells/mm³, which recognises the important component of 'when to start' and the role that timing of initiation plays in reducing mortality and disease progression. The data on 'what to star...
Saved in:
Main Authors: | Prinitha Pillay (Author), Vivian Black (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2012-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efavirenz in pregnancy
by: Polly Clayden, et al.
Published: (2010) -
Mediastinal teratoma: Simplicity in diagnosis and therapy
by: Pravin Kammar, et al.
Published: (2016) -
Efavirenz Conceptions and Regimen Management in a Prospective Cohort of Women on Antiretroviral Therapy
by: Sheree Schwartz, et al.
Published: (2012) -
On the Benefits of Rational Simplicity: How to Teach Humanities in Technical Universities?
by: E. N. Ivakhnenko, et al.
Published: (2022) -
Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study
by: Rebecca Zash, MD, et al.
Published: (2018)